8-K Announcements
6Material company update
Apr 3, 2026·SEC
Material company update
Mar 20, 2026·SEC
Material company update
Mar 6, 2026·SEC
Agilent Technologies, Inc.(A)Earnings, Financials & Key Ratios
A•NYSE
$117.53
$33.27B mkt cap·25.7× P/E·Price updated May 6, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryLife Science Instruments and Sequencing Tools
AboutAgilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.Show more
- Revenue$6.95B+6.7%
- EBITDA$1.77B+1.3%
- Net Income$1.3B+1.1%
- EPS (Diluted)4.57+3.2%
- Gross Margin52.43%-3.4%
- EBITDA Margin25.43%-5.1%
- Operating Margin21.29%-6.9%
- Net Margin18.75%-5.3%
- ROE20.62%-6.1%
- ROIC13.49%-8.6%
- Debt/Equity0.50-17.9%
- Interest Coverage13.21-14.8%
A Key Insights
Agilent Technologies, Inc. (A) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 21.6%
- ✓FCF machine: 16.6% free cash flow margin
- ✓10 consecutive years of dividend growth
- ✓Share count reduced 2.4% through buybacks
- ✓Healthy 5Y average net margin of 18.8%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
A Price & Volume
Agilent Technologies, Inc. (A) stock price & volume — 10-year historical chart
Loading chart...
A Growth Metrics
Agilent Technologies, Inc. (A) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.58%
5 Years5.41%
3 Years0.48%
TTM8.14%
Profit CAGR
10 Years12.51%
5 Years12.63%
3 Years1.29%
TTM2.46%
EPS CAGR
10 Years14.31%
5 Years14.72%
3 Years3.02%
TTM4.14%
Return on Capital
10 Years13.66%
5 Years15.86%
3 Years15.09%
Last Year14.55%
A Recent Earnings
Agilent Technologies, Inc. (A) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 9/12 qtrs (75%)
Q1 2026Latest
Feb 25, 2026EPS
$1.36
Est $1.37
-0.7%
Revenue
$1.8B
Est $1.8B
-0.5%
Q4 2025
Nov 24, 2025EPS
$1.59
Est $1.58
+0.4%
Revenue
$1.8B
Est $1.8B
+0.4%
Q3 2025
Aug 27, 2025EPS
$1.37
Est $1.37
+0.0%
Revenue
$1.7B
Est $1.7B
+3.2%
Q2 2025
May 28, 2025EPS
$1.31
Est $1.26
+4.0%
Revenue
$1.7B
Est $1.6B
+2.5%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 25, 2026 | $1.36vs $1.37-0.7% | $1.8Bvs $1.8B-0.5% |
| Q4 2025 | Nov 24, 2025 | $1.59vs $1.58+0.4% | $1.8Bvs $1.8B+0.4% |
| Q3 2025 | Aug 27, 2025 | $1.37vs $1.37+0.0% | $1.7Bvs $1.7B+3.2% |
| Q2 2025 | May 28, 2025 | $1.31vs $1.26+4.0% | $1.7Bvs $1.6B+2.5% |
Based on last 12 quarters of dataView full earnings history →
A Peer Comparison
Agilent Technologies, Inc. (A) competitors in Life Science Instruments and Sequencing Tools — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 WAT | 20.38B | 342.53 | 31.83 | 6.99% | 11.91% | 8.04% | 2.65% | 0.55 |
 TMO | 173.46B | 466.76 | 26.31 | 3.91% | 15.18% | 13.23% | 3.63% | 0.76 |
 DHR | 123.6B | 174.63 | 34.65 | 2.9% | 14.89% | 7.06% | 4.26% | 0.35 |
 BRKR | 5.77B | 38.01 | 50.01 | 13.56% | -0.25% | -0.34% | 2.36% | 1.24 |
 MTD | 26.47B | 1302.42 | 30.89 | 3.98% | 21.59% | 3.21% | ||
 BIO | 6.94B | 257.12 | 9.23 | 0.65% | 6.52% | 2.4% | 5.4% | 0.21 |
 RGEN | 7.09B | 125.71 | 146.17 | 16.36% | 6.73% | 2.46% | 1.32% | 0.33 |
 IDXX | 44.83B | 562.97 | 43.04 | 10.42% | 24.63% | 70.87% | 2.35% | 0.67 |
Compare A vs Peers
Agilent Technologies, Inc. (A) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
A Income Statement
Agilent Technologies, Inc. (A) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Oct'17 | Oct'18 | Oct'19 | Oct'20 | Oct'21 | Oct'22 | Oct'23 | Oct'24 | Oct'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 4.47B | 4.91B | 5.16B | 5.34B | 6.32B | 6.85B | 6.83B | 6.51B | 6.95B | 7.07B |
| Revenue Growth % | 6.43% | 9.88% | 5.07% | 3.41% | 18.36% | 8.37% | -0.22% | -4.73% | 6.73% | 8.14% |
| Cost of Goods Sold | 2.06B | 2.23B | 2.36B | 2.5B | 2.91B | 3.13B | 3.37B | 2.98B | 3.31B | 2.52B |
| COGS % of Revenue | 46.13% | 45.32% | 45.67% | 46.86% | 46.08% | 45.65% | 49.29% | 45.7% | 47.57% | - |
| Gross Profit | 2.41B▲ 0% | 2.69B▲ 11.5% | 2.81B▲ 4.4% | 2.84B▲ 1.1% | 3.41B▲ 20.1% | 3.72B▲ 9.2% | 3.46B▼ 6.9% | 3.54B▲ 2.0% | 3.64B▲ 3.1% | 2.74B▲ 0% |
| Gross Margin % | 53.87% | 54.68% | 54.33% | 53.14% | 53.92% | 54.35% | 50.71% | 54.3% | 52.43% | 38.84% |
| Gross Profit Growth % | 9.65% | 11.54% | 4.39% | 1.14% | 20.09% | 9.25% | -6.9% | 2.02% | 3.06% | - |
| Operating Expenses | 1.57B | 1.78B | 1.86B | 1.99B | 2.06B | 2.1B | 2.12B | 2.05B | 2.16B | 2.23B |
| OpEx % of Revenue | 35.06% | 36.14% | 36.1% | 37.29% | 32.6% | 30.72% | 30.95% | 31.44% | 31.15% | - |
| Selling, General & Admin | 1.23B | 1.37B | 1.46B | 1.5B | 1.62B | 1.64B | 1.63B | 1.52B | 1.71B | 1.77B |
| SG&A % of Revenue | 27.48% | 27.96% | 28.28% | 28.02% | 25.62% | 23.9% | 23.91% | 23.32% | 24.6% | - |
| Research & Development | 339M | 385M | 404M | 495M | 441M | 467M | 481M | 479M | 455M | 459M |
| R&D % of Revenue | 7.58% | 7.83% | 7.82% | 9.27% | 6.98% | 6.82% | 7.04% | 7.36% | 6.55% | - |
| Other Operating Expenses | 0 | 17M | 0 | 0 | 0 | 0 | 0 | 50M | 0 | 0 |
| Operating Income | 841M▲ 0% | 904M▲ 7.5% | 941M▲ 4.1% | 846M▼ 10.1% | 1.35B▲ 59.2% | 1.62B▲ 20.1% | 1.35B▼ 16.6% | 1.49B▲ 10.2% | 1.48B▼ 0.6% | 1.46B▲ 0% |
| Operating Margin % | 18.81% | 18.4% | 18.23% | 15.85% | 21.32% | 23.63% | 19.76% | 22.86% | 21.29% | 20.61% |
| Operating Income Growth % | 36.75% | 7.49% | 4.09% | -10.1% | 59.22% | 20.12% | -16.56% | 10.22% | -0.6% | - |
| EBITDA | 1.05B | 1.11B | 1.18B | 1.15B | 1.67B | 1.94B | 1.62B | 1.75B | 1.77B | 1.67B |
| EBITDA Margin % | 23.59% | 22.67% | 22.84% | 21.61% | 26.4% | 28.26% | 23.72% | 26.8% | 25.43% | 23.67% |
| EBITDA Growth % | 22.39% | 5.59% | 5.83% | -2.12% | 44.54% | 16.01% | -16.23% | 7.65% | 1.26% | -4.29% |
| D&A (Non-Cash Add-back) | 214M | 210M | 238M | 308M | 321M | 317M | 271M | 257M | 288M | 216M |
| EBIT | 882M | 1.02B | 993M | 920M | 1.44B | 1.59B | 1.43B | 1.62B | 1.55B | 1.15B |
| Net Interest Income | -57M | -37M | -38M | -70M | -79M | -75M | -44M | -16M | -50M | -37M |
| Interest Income | 22M | 38M | 36M | 8M | 2M | 9M | 51M | 80M | 62M | 62M |
| Interest Expense | 79M | 75M | 74M | 78M | 81M | 84M | 95M | 96M | 112M | 59M |
| Other Income/Expense | -38M | 42M | -22M | -4M | 13M | -114M | -11M | 33M | -44M | -24M |
| Pretax Income | 803M▲ 0% | 946M▲ 17.8% | 919M▼ 2.9% | 842M▼ 8.4% | 1.36B▲ 61.5% | 1.5B▲ 10.6% | 1.34B▼ 11.0% | 1.52B▲ 13.6% | 1.44B▼ 5.7% | 1.43B▲ 0% |
| Pretax Margin % | 17.96% | 19.25% | 17.8% | 15.77% | 21.52% | 21.96% | 19.6% | 23.36% | 20.65% | 20.27% |
| Income Tax | 119M | 630M | -152M | 123M | 150M | 250M | 99M | 232M | 132M | 142M |
| Effective Tax Rate % | 14.82% | 66.6% | -16.54% | 14.61% | 11.03% | 16.62% | 7.39% | 15.25% | 9.2% | 9.92% |
| Net Income | 684M▲ 0% | 316M▼ 53.8% | 1.07B▲ 238.9% | 719M▼ 32.9% | 1.21B▲ 68.3% | 1.25B▲ 3.6% | 1.24B▼ 1.1% | 1.29B▲ 4.0% | 1.3B▲ 1.1% | 1.29B▲ 0% |
| Net Margin % | 15.3% | 6.43% | 20.74% | 13.47% | 19.15% | 18.31% | 18.15% | 19.8% | 18.75% | 18.26% |
| Net Income Growth % | 48.7% | -53.8% | 238.92% | -32.87% | 68.29% | 3.64% | -1.12% | 3.95% | 1.09% | 2.46% |
| Net Income (Continuing) | 684M | 316M | 1.07B | 719M | 1.21B | 1.25B | 1.24B | 1.29B | 1.3B | 1.29B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 4M | 4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 2.10▲ 0% | 0.97▼ 53.8% | 3.37▲ 247.4% | 2.30▼ 31.8% | 3.94▲ 71.3% | 4.18▲ 6.1% | 4.19▲ 0.2% | 4.43▲ 5.7% | 4.57▲ 3.2% | 4.54▲ 0% |
| EPS Growth % | 50% | -53.81% | 247.42% | -31.75% | 71.3% | 6.09% | 0.24% | 5.73% | 3.16% | 4.14% |
| EPS (Basic) | 2.12 | 0.98 | 3.41 | 2.33 | 3.98 | 4.19 | 4.22 | 4.44 | 4.59 | - |
| Diluted Shares Outstanding | 326M | 325M | 318M | 312M | 307M | 300M | 296M | 291M | 284M | 284M |
| Basic Shares Outstanding | 322M | 321M | 314M | 309M | 304M | 299M | 294M | 290M | 283M | 283M |
| Dividend Payout Ratio | 24.85% | 60.44% | 19.23% | 30.88% | 19.5% | 19.94% | 21.37% | 21.26% | 21.64% | - |
A Balance Sheet
Agilent Technologies, Inc. (A) balance sheet — assets, liabilities & shareholders' equity
| Line item | Oct'17 | Oct'18 | Oct'19 | Oct'20 | Oct'21 | Oct'22 | Oct'23 | Oct'24 | Oct'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 4.17B | 3.85B | 3.19B | 3.42B | 3.8B | 3.78B | 4.19B | 3.96B | 4.59B | 4.62B |
| Cash & Short-Term Investments | 2.68B | 2.25B | 1.38B | 1.44B | 1.57B | 1.05B | 1.59B | 1.33B | 1.79B | 1.76B |
| Cash Only | 2.68B | 2.25B | 1.38B | 1.44B | 1.48B | 1.05B | 1.59B | 1.33B | 1.79B | 1.76B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 91M | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 724M | 776M | 930M | 1.04B | 1.17B | 1.41B | 1.29B | 1.32B | 1.49B | 1.52B |
| Days Sales Outstanding | 59.09 | 57.64 | 65.75 | 70.96 | 67.7 | 74.89 | 68.96 | 74.23 | 78.12 | 74.34 |
| Inventory | 575M | 638M | 679M | 720M | 830M | 1.04B | 1.03B | 991M | 1.02B | 1.06B |
| Days Inventory Outstanding | 101.73 | 104.57 | 105.1 | 105.04 | 104.03 | 121.2 | 111.73 | 121.58 | 113.2 | 147.89 |
| Other Current Assets | 192M | 187M | 198M | 216M | 222M | 282M | 274M | 315M | 293M | 277M |
| Total Non-Current Assets | 4.26B | 4.69B | 6.26B | 6.21B | 6.91B | 6.75B | 6.58B | 7.89B | 8.13B | 8.2B |
| Property, Plant & Equipment | 757M | 822M | 850M | 845M | 945M | 1.1B | 1.42B | 1.96B | 2.02B | 2.08B |
| Fixed Asset Turnover | 5.91x | 5.98x | 6.07x | 6.32x | 6.69x | 6.23x | 4.80x | 3.33x | 3.43x | 3.54x |
| Goodwill | 2.61B | 2.97B | 3.59B | 3.6B | 3.98B | 3.95B | 3.96B | 4.47B | 4.47B | 4.48B |
| Intangible Assets | 361M | 491M | 1.11B | 831M | 981M | 821M | 475M | 547M | 445M | 426M |
| Long-Term Investments | 138M | 68M | 102M | 158M | 185M | 195M | 164M | 175M | 133M | 538M |
| Other Non-Current Assets | 394M | 339M | 611M | 776M | 820M | 686M | 554M | 297M | 1.06B | 4B |
| Total Assets | 8.43B▲ 0% | 8.54B▲ 1.4% | 9.45B▲ 10.7% | 9.63B▲ 1.9% | 10.71B▲ 11.2% | 10.53B▼ 1.6% | 10.76B▲ 2.2% | 11.85B▲ 10.1% | 12.73B▲ 7.4% | 12.81B▲ 0% |
| Asset Turnover | 0.53x | 0.58x | 0.55x | 0.55x | 0.59x | 0.65x | 0.63x | 0.55x | 0.55x | 0.57x |
| Asset Growth % | 8.11% | 1.36% | 10.67% | 1.85% | 11.2% | -1.62% | 2.19% | 10.06% | 7.44% | 38.16% |
| Total Current Liabilities | 1.26B | 1.17B | 2.08B | 1.47B | 1.71B | 1.86B | 1.6B | 1.9B | 2.35B | 2.23B |
| Accounts Payable | 305M | 340M | 354M | 354M | 446M | 580M | 418M | 540M | 570M | 602M |
| Days Payables Outstanding | 53.96 | 55.73 | 54.8 | 51.64 | 55.9 | 67.72 | 45.3 | 66.25 | 62.95 | 80.26 |
| Short-Term Debt | 210M | 0 | 616M | 75M | 0 | 36M | 0 | 45M | 304M | 304M |
| Deferred Revenue (Current) | 291M | 324M | 336M | 386M | 441M | 461M | 505M | 544M | 624M | 2.55B |
| Other Current Liabilities | 276M | 304M | 334M | 367M | 493M | 455M | 371M | 326M | 443M | 646M |
| Current Ratio | 3.30x | 3.29x | 1.53x | 2.33x | 2.22x | 2.03x | 2.61x | 2.09x | 1.96x | 1.96x |
| Quick Ratio | 2.85x | 2.74x | 1.21x | 1.84x | 1.74x | 1.47x | 1.97x | 1.57x | 1.52x | 1.52x |
| Cash Conversion Cycle | 106.86 | 106.48 | 116.05 | 124.36 | 115.83 | 128.36 | 135.39 | 129.57 | 128.37 | 141.98 |
| Total Non-Current Liabilities | 2.33B | 2.8B | 2.62B | 3.29B | 3.61B | 3.37B | 3.31B | 4.05B | 3.64B | 3.67B |
| Long-Term Debt | 1.8B | 1.8B | 1.79B | 2.28B | 2.73B | 2.73B | 2.73B | 3.35B | 3.05B | 3.05B |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 142M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 527M | 1B | 833M | 1B | 879M | 633M | 580M | 566M | 589M | 2.48B |
| Total Liabilities | 3.59B | 3.97B | 4.7B | 4.75B | 5.32B | 5.23B | 4.92B | 5.95B | 5.99B | 5.91B |
| Total Debt | 2.01B | 1.8B | 2.41B | 2.36B | 2.73B | 2.77B | 2.73B | 3.57B | 3.35B | 3.35B |
| Net Debt | -667M | -448M | 1.02B | 918M | 1.25B | 1.72B | 1.15B | 2.25B | 1.56B | 1.6B |
| Debt / Equity | 0.42x | 0.39x | 0.51x | 0.48x | 0.51x | 0.52x | 0.47x | 0.61x | 0.50x | 0.50x |
| Debt / EBITDA | 1.91x | 1.61x | 2.04x | 2.04x | 1.64x | 1.43x | 1.69x | 2.05x | 1.90x | 2.01x |
| Net Debt / EBITDA | -0.63x | -0.40x | 0.87x | 0.80x | 0.75x | 0.89x | 0.71x | 1.29x | 0.89x | 0.89x |
| Interest Coverage | 10.65x | 12.05x | 12.72x | 10.85x | 16.63x | 19.26x | 14.21x | 15.50x | 13.21x | 19.53x |
| Total Equity | 4.83B▲ 0% | 4.57B▼ 5.5% | 4.75B▲ 3.9% | 4.87B▲ 2.6% | 5.39B▲ 10.6% | 5.3B▼ 1.6% | 5.84B▲ 10.2% | 5.9B▲ 0.9% | 6.74B▲ 14.3% | 6.91B▲ 0% |
| Equity Growth % | 13.87% | -5.46% | 3.87% | 2.63% | 10.59% | -1.56% | 10.18% | 0.91% | 14.29% | 35.57% |
| Book Value per Share | 14.83 | 14.06 | 14.93 | 15.62 | 17.55 | 17.68 | 19.75 | 20.27 | 23.74 | 24.32 |
| Total Shareholders' Equity | 4.83B | 4.57B | 4.75B | 4.87B | 5.39B | 5.3B | 5.84B | 5.9B | 6.74B | 6.91B |
| Common Stock | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 3M |
| Retained Earnings | -126M | -336M | -18M | 81M | 348M | 324M | 782M | 750M | 1.39B | 1.48B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -352M | -408M | -514M | -522M | -282M | -347M | -327M | -305M | -226M | -184M |
| Minority Interest | 4M | 4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A Cash Flow Statement
Agilent Technologies, Inc. (A) cash flow — operating, investing & free cash flow history
| Line item | Oct'17 | Oct'18 | Oct'19 | Oct'20 | Oct'21 | Oct'22 | Oct'23 | Oct'24 | Oct'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 889M | 1.09B | 1.02B | 921M | 1.49B | 1.31B | 1.77B | 1.75B | 1.56B | 1.56B |
| Operating CF Margin % | 19.88% | 22.12% | 19.78% | 17.25% | 23.5% | 19.16% | 25.93% | 26.9% | 22.44% | - |
| Operating CF Growth % | 12.11% | 22.27% | -6.07% | -9.79% | 61.24% | -11.65% | 35.06% | -1.19% | -10.97% | -78.06% |
| Net Income | 684M | 316M | 1.07B | 719M | 1.21B | 1.25B | 1.24B | 1.29B | 434M | 1.29B |
| Depreciation & Amortization | 212M | 210M | 238M | 308M | 321M | 317M | 271M | 257M | 288M | 283M |
| Stock-Based Compensation | 60M | 70M | 72M | 83M | 110M | 125M | 111M | 129M | 128M | 129M |
| Deferred Taxes | 102M | -16M | -255M | 29M | 14M | 8M | -56M | -64M | -130M | -95M |
| Other Non-Cash Items | -71M | 36M | 283M | 78M | -68M | 86M | 322M | 57M | 897M | 102M |
| Working Capital Changes | -98M | 471M | -388M | -296M | -102M | -478M | -116M | 83M | -58M | -313M |
| Change in Receivables | -81M | -65M | -106M | -107M | -128M | -321M | 132M | 7M | -149M | -137M |
| Change in Inventory | -61M | -83M | -36M | -68M | -136M | -248M | -33M | 34M | 45M | -96M |
| Change in Payables | 2M | 40M | 30M | 2M | 64M | 121M | -171M | 103M | 16M | 52M |
| Cash from Investing | -305M | -704M | -1.59B | -147M | -749M | -338M | -310M | -1.26B | -394M | -393M |
| Capital Expenditures | -176M | -177M | -156M | -119M | -189M | -291M | -298M | -378M | -207M | -403M |
| CapEx % of Revenue | 3.94% | 3.6% | 3.02% | 2.23% | 2.99% | 4.25% | 4.36% | 5.81% | 2.98% | - |
| Acquisitions | -126M | -516M | -1.41B | 1M | -546M | -52M | -1M | -862M | 4M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -2M | -1M | -2M | -8M | -4M | -4M | -8M | -13M | -199M | 7M |
| Cash from Financing | -202M | -797M | -299M | -717M | -696M | -1.37B | -930M | -752M | -715M | -757M |
| Debt Issued (Net) | 110M | -693M | 600M | -45M | 356M | 26M | -35M | 637M | -41M | -16M |
| Equity Issued (Net) | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -4M |
| Dividends Paid | -170M | -191M | -206M | -222M | -236M | -250M | -265M | -274M | -282M | -283M |
| Share Repurchases | -194M | -422M | -723M | -469M | -788M | -1.14B | -575M | -1.15B | -425M | -487M |
| Other Financing | 52M | 509M | 46M | 19M | -28M | 58M | -55M | 35M | -39M | -14M |
| Net Change in Cash | 389M▲ 0% | -431M▼ 210.8% | -866M▼ 100.9% | 59M▲ 106.8% | 43M▼ 27.1% | -434M▼ 1109.3% | 537M▲ 223.7% | -261M▼ 148.6% | 459M▲ 275.9% | 290M▲ 0% |
| Free Cash Flow | 713M▲ 0% | 910M▲ 27.6% | 865M▼ 4.9% | 802M▼ 7.3% | 1.3B▲ 61.6% | 1.02B▼ 21.2% | 1.47B▲ 44.4% | 1.37B▼ 6.9% | 1.15B▼ 16.1% | 993M▲ 0% |
| FCF Margin % | 15.94% | 18.52% | 16.75% | 15.02% | 20.51% | 14.91% | 21.57% | 21.09% | 16.58% | 14.06% |
| FCF Growth % | 9.02% | 27.63% | -4.95% | -7.28% | 61.6% | -21.22% | 44.37% | -6.85% | -16.1% | -24.31% |
| FCF per Share | 2.19 | 2.80 | 2.72 | 2.57 | 4.22 | 3.40 | 4.98 | 4.72 | 4.06 | 4.06 |
| FCF Conversion (FCF/Net Income) | 1.30x | 3.44x | 0.95x | 1.28x | 1.23x | 1.05x | 1.43x | 1.36x | 1.20x | 0.77x |
| Interest Paid | 82M | 80M | 80M | 71M | 76M | 85M | 89M | 80M | 0 | 52M |
| Taxes Paid | 63M | 102M | 159M | 361M | 211M | 279M | 199M | 314M | 0 | 285M |
A Key Ratios
Agilent Technologies, Inc. (A) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 15.06% | 6.72% | 22.99% | 14.95% | 23.58% | 23.45% | 22.24% | 21.95% | 20.62% | 18.67% |
| Return on Invested Capital (ROIC) | 15.71% | 16.36% | 14.26% | 10.97% | 16.26% | 17.77% | 14.45% | 14.75% | 13.49% | 13.49% |
| Gross Margin | 53.87% | 54.68% | 54.33% | 53.14% | 53.92% | 54.35% | 50.71% | 54.3% | 52.43% | 38.84% |
| Net Margin | 15.3% | 6.43% | 20.74% | 13.47% | 19.15% | 18.31% | 18.15% | 19.8% | 18.75% | 18.26% |
| Debt / Equity | 0.42x | 0.39x | 0.51x | 0.48x | 0.51x | 0.52x | 0.47x | 0.61x | 0.50x | 0.50x |
| Interest Coverage | 10.65x | 12.05x | 12.72x | 10.85x | 16.63x | 19.26x | 14.21x | 15.50x | 13.21x | 19.53x |
| FCF Conversion | 1.30x | 3.44x | 0.95x | 1.28x | 1.23x | 1.05x | 1.43x | 1.36x | 1.20x | 0.77x |
| Revenue Growth | 6.43% | 9.88% | 5.07% | 3.41% | 18.36% | 8.37% | -0.22% | -4.73% | 6.73% | 8.14% |
A SEC Filings & Documents
Agilent Technologies, Inc. (A) SEC filings — annual & quarterly reports (10-K, 10-Q)
A Frequently Asked Questions
Agilent Technologies, Inc. (A) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Agilent Technologies, Inc. (A) reported $7.07B in revenue for fiscal year 2025. This represents a 11% decrease from $7.95B in 1998.
Agilent Technologies, Inc. (A) grew revenue by 6.7% over the past year. This is steady growth.
Yes, Agilent Technologies, Inc. (A) is profitable, generating $1.29B in net income for fiscal year 2025 (18.8% net margin).
Dividend & Returns
Yes, Agilent Technologies, Inc. (A) pays a dividend with a yield of 0.84%. This makes it attractive for income-focused investors.
Agilent Technologies, Inc. (A) has a return on equity (ROE) of 20.6%. This is excellent, indicating efficient use of shareholder capital.
Agilent Technologies, Inc. (A) generated $993.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More A
Agilent Technologies, Inc. (A) financial analysis — history, returns, DCA and operating performance tools
Full A Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates